Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Melatonin directly affects mouse hair follicles and may influence hair growth.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Long-COVID has diverse, long-term health impacts, especially in young people.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Guasha changed rat skin appearance and blood vessels temporarily without affecting certain nerve proteins or fiber structure.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Essential oils in cosmetics can offer benefits but may cause allergies and should be used carefully.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

The document explains how to do skin procedures, care after surgery, and when to use certain treatments.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Hormonal therapies are safe and effective for treating adult women's acne.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Red clover extract-based scalp treatments significantly improved hair volume and reduced hair loss and damage.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.